Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toward drugs derived from cannabis.

R Mechoulam, E A Carlini

    Die Naturwissenschaften
    |April 1, 1978
    PubMed
    Summary

    Natural and synthetic cannabinoids show therapeutic potential. Delta1-Tetrahydrocannabinol (delta1-THC) is studied for glaucoma, asthma, and chemotherapy side effects, while cannabidiol is explored for epilepsy and sleep disorders.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression.

    Journal of psychiatric research·2024
    Same author

    Use of South American plants for the treatment of neuropsychiatric disorders.

    International psychiatry : bulletin of the Board of International Affairs of the Royal College of Psychiatrists·2019
    Same author

    Acute oral cannabidiolic acid methyl ester reduces depression-like behavior in two genetic animal models of depression.

    Behavioural brain research·2018
    Same author

    Pharmacological and Toxicological Study of Maytenus ilicifolia Leaf Extract Part II-Clinical Study (Phase I).

    Phytotherapy research : PTR·2017
    Same author

    Cannabis and epilepsy.

    Epilepsy & behavior : E&B·2017
    Same author

    In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

    Current oncology (Toronto, Ont.)·2016

    Area of Science:

    • Pharmacology and Medicinal Chemistry
    • Neuroscience

    Background:

    • Review of current research on natural and synthetic cannabinoids for therapeutic applications.
    • Focus on the evolving role of cannabinoids in drug development.

    Observation:

    • Delta1-Tetrahydrocannabinol (delta1-THC) is under investigation for glaucoma, asthma, and as an antiemetic in cancer chemotherapy.
    • Cannabidiol is being clinically evaluated for epilepsy and as a hypnotic agent.
    • Numerous synthetic cannabinoids are being explored for analgesic and sedative-relaxant properties.

    Findings:

    • Cannabinoids exhibit a diverse range of pharmacological activities.
    • Both natural and synthetic compounds show promise in treating various medical conditions.

    Implications:

    • Potential for novel drug development targeting conditions like glaucoma, epilepsy, and pain.
    • Further research into synthetic cannabinoids may yield new therapeutic agents with improved profiles.

    Related Experiment Videos